The current outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) and Uganda which began only a couple of weeks ago is already reportedly the third largest in history and, according to the World Health Organization’s (WHO) Director-General Tedros Adhanom Ghebreyesus, “spreading rapidly,” with more than 900 suspected cases of the disease and 223 suspected deaths associated with it. Of those, 112 cases and 11 deaths have been confirmed.1 2
The epicenter of the outbreak are the provinces of North Kivu and Ituri in the eastern part of the DRC where there are ongoing armed conflicts between the DRC military forces and rebel militia groups.1 2
According to Satish Pillai, MD, the incident manager for the U.S. Centers for Disease Control and Prevention’s (CDC) Ebola response, the agency has sent 20 epidemiologists to the DRC and is training 50 community health care workers there.2
There are currently three licensed vaccines prequalified by the World Health Organization (WHO) designed to protect against Ebola virus disease. Ervebo (rVSV-ZEBOV-GP), manufactured by Merck & Co., is a live attenuated Ebola vaccine that was approved by the U.S. Food and Drug Administration (FDA) in 2019. In 2020, the European Medicines Agency (EMA) approved the Zabdeno (Ad26.ZEB), which is a viral vector (VSV) platform Ebola vaccine, and Mvabean ((MVA-BN-Filo), which is a modified vaccinia virus Ankara (MVA) platform Ebola vaccine. Both of those Ebola vaccines are manufactured by Johnson & Johnson Innovative Medicine (formerly Janssen).3 4
However, none of these vaccines were developed to target the Bundibugyo strain of the Ebola virus. “This species of Ebola is one for which there is no licensed vaccine or treatment,” said Anne Ancia, the WHO’s representative in the DRC.5
As infectious disease physician Amesh Adalja, MD of the Johns Hopkins Center for Health Security pointed out:
Most of Ebola countermeasure development has been focused on Ebola Zaire, which was traditionally the more deadly strain and has always been the more common strain behind outbreaks. That also means that a lot of the other Ebola strains have not necessarily had that same level of vaccine development.5
New Oxford University and Merck Ebola Vaccines Months Away from Clinical Trials
At least three vaccines are under development to deal with this rare strain. The University of Oxford in England is working on a new vaccine for Ebola Bundibugyo that would be based on AstraZeneca plc’s adenovirus vectored ChAdOx1 (Vaxzevria or Covishield) vaccine. It is expected to be ready for human clinical trials within two to three months. Animal testing of the vaccine is already underway.
The Serum Institute of India has agreed to mass produce the Oxford vaccine as soon as the university is ready to supply the necessary medical-grade material. “Once we get starting material to them they can go fast and they can go big,” said vaccinologist Teresa Lambe, PhD of the Oxford Vaccine Group.6
It’s worth noting that there were serious problems with the ChAdOx1 vaccine and it was never approved by the FDA. The vaccine was determined to cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) which causes blood clots and low platelet counts that, in some cases, led to the injury and death recipients. TTS was listed as a warning in the product insert for the vaccine in the United Kingdom and other countries.7
Prior to the TTS warning for ChAdOx1, the EMA had added an autoimmune neurological disorder known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information.8 The EMA stated:
GBS was identified during the marketing authorization process as a possible adverse event requiring specific safety monitoring activities8.
The BBC reported that there is another experimental Ebola Bundibugyo vaccine being developed, but that it is not expected to be ready for testing for another six to nine months. That vaccine is likely the one based on Merck’s live attenuated Ervebo for the Ebola Zaire strain. It has been designated as rVSVΔG/BDBV-GP and has been reported to show a “survival benefit” in animals. But you have to wonder about the wisdom of introducing a live attenuated Ebola vaccine and the possibility of dramatically compounding the problem by spreading the deadly virus through shedding.5 9
An mRNA-based Ebola Vaccine?
Work on development of a third Ebola Bundibugyo vaccine is also underway by Oxford University. In January 2026, the Coalition for Epidemic Preparedness Innovations (CEPI), co-founded and heavily funded by the Bill & Melinda Gates Foundation, awarded Oxford a contract to begin development of an mRNA (messenger RNA) based Ebola Bundibugyo vaccine. Note that this was just four months before the WHO declared the latest Ebola outbreak in the DRC a global health emergency.10 11
Given all the safety issues (notably severe inflammation of the heart and turbo cancers) associated with the experimental mRNA technology used to develop the COVID-19 shots, the idea of pursuing this research path should also give the public some measure of pause.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:1 Winsor M, Kekatos M, Benadjaoud Y. Ebola outbreak in DRC is ‘spreading rapidly’ with almost 750 suspected cases: WHO chief. ABC News May 23, 2026.
2 Van Beusekom M. DR Congo Ebola outbreak reaches nearly 750 suspected cases, 177 deaths as area risk upgraded to ‘very high’. CIDRAP May 22, 2026.
3 Stewart J. Ervebo FDA Approval History. Drugs.com Aug. 7, 2023.
4 Press Release. Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine. Johnson & Johnson July 1, 2020.
5 Adepoju P. Ebola vaccines exist, but not for the strain in the current outbreak. Scientific American May 20, 2026.
6 Gallagher J. UK scientists developing Ebola vaccine that could be ready for trials in months. BBC May 22, 2026.
7 Hendler C. AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects. The Vaccine Reaction May 20, 2024.
8 TVR Staff. Guillain-Barré Syndrome Warning Added to AstraZeneca’s Vaxzevria COVID Vaccine in Europe. The Vaccine Reaction Sept. 12, 2021.
9 Sunny ME, Rigby J. Bundibugyo Ebola vaccines and treatments in development. Reuters May 21, 2026.
10 Hulscher N. Moderna Began Developing a Bundibugyo Ebola mRNA “Vaccine” Just 4 Months Before WHO Declared a Global Emergency. GlobalResearch May 18, 2026.
11 Mukhwana T. WHO declares Ebola outbreak in DR Congo an international emergency. BBC May 18, 2026.
6 Responses
Has this site turned into rhetoric and propaganda pushing? Ebola has a low infection spread rate it’s not airborne. Has a high burn out rate bc it’s so aggressive. More propaganda.
I consider this ebola article to be the most rational of those I’ve seen. Look at the discrepancy between cases reported & cases confirmed- have not seen this in other articles, have not seen this mentioned. Retired RN here- last ebola outbreak 2014 was actually very serious compared to this BUT the disease does not survive in environments that have airconditioning & modern clean water sanitation- this tells me everything I need to know about- it is a 3rd world crappy living conditions disease.
Reporting on vaccine “development” to inform and empower the public is not propaganda nor is it promoting vaccine use.
When the fear is driven up, people will grasp at anything that claims to protect them
sad
For all the money spent on vaccines, they could have built up entire communities with clean safe water access, hygienic support, toilets, soaps, refrigeration and electricity access, basic hygienic education for the masses. You know, what actually cut down communicable disease to irrelevant levels in the western world.
A vaccine even if effective does not solve the root cause of the problem which is cultural in nature. It is the culture of accepting unsanitary conditions why disease spreads in the first place. We’re seeing a lot more of that here in the USA. Did you know that in Spanish and many other Latin American cultures, it’s machismo for men to not wash their hands after using restrooms? The men will make fun of each other for performing simple actions like washing their hands after using the restroom.
This is in part where the stereotypical liberal woman argument comes from, why it’s always the ladies whom are the most adamant supporters of chain migration. In part also why there is a resurgence of conservatism among young men in this country. Some people see this first hand, others do not. The steady stream of migrants not washing their hands as they leave restrooms, do dirty jobs, etc.
Same thing in Africa, the middle east, many other parts of the world. The cultural priorities are not focused very much at all on hygiene. You can’t vaccinate that away. But we could stop wasting trillions of dollars and untold man hours on vaccination programs and instead use the money in a wiser fashion and reform culture where the people are from. None of this is really honestly caring about health, or they’d prioritize something other than the most profitable pharmasuetical product in the world; vaccines. There are volunteer do gooders whom routinely travel to these parts of the world whom personally put together many different medicines and herbal formulas which do a really great job at mitigating the issues. And they get the job done for a thousand thousand times less cost than ‘vaccines’ and vaccine research. There is no corporate profit, why they get inadequate attention and funding. As usual; central planning never works.
It’s rather inadequate journalism to talk about vaccines in third world areas in this regard, and not also talk about the extreme lack of resources and cultural understanding relating to the importance of hygienic practices, as well as the extreme misappropriation of money into vaccination research industries. Framing the issue as if vaccines are the only solution, which they are not. Where is Mother Mary when you need her?
5G and other unnatural radiation cause blood clumping in 5min, could be far quicker or slower, depending on radiation intensity. The world is now full of ‘smart’ permanently connected radiation emitters and local radar systems to monitor everybody. On the flip of a digital switch, severe illness/death can be turned on. So except for those in the know, the masses will be completely convinced if they make an emergency event happen.
Ebola is a patented pathogen to solidify the belief in pandemonial pathogens, but in the same logic any poison could be patented and relabeled a pathogen necessitating the ‘approved’ injection. It just doesn’t exist, people who can cure it are kept away, ebo is a F!e’m<a killcamp where nobody gets in or out and the narrative is fully controlled like many times before where those who declare it always take your liberty away. Do not comply, as the long term cost will outweigh the short one. Live saving miracle cures are never used, only narrative protocol, so use what's between your ears. Fear is only useful when facing an immediate physical danger. Living healthy will help everybody.